(R)-1-(2,6-Dichlorophenyl)ethanamine hydrochloride
95%
- Product Code: 73153
CAS:
1982270-14-3
| Molecular Weight: | 226.53 g./mol | Molecular Formula: | C₈H₁₀Cl₃N |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD12757835 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature, inert gas |
Product Description:
This compound is primarily used in the pharmaceutical industry as a chiral intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its stereospecific structure makes it valuable in the production of enantiomerically pure drugs, particularly those targeting the central nervous system. It is often employed in the development of analgesics and anesthetics, where its specific configuration enhances the efficacy and reduces side effects of the final drug product. Additionally, it serves as a building block in organic synthesis for creating complex molecules with high pharmacological activity. Its application is critical in ensuring the desired therapeutic outcomes of medications while maintaining safety and regulatory compliance.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿11,070.00 |
+
-
|
| 0.250 | 10-20 days | ฿17,721.00 |
+
-
|
| 1.000 | 10-20 days | ฿38,088.00 |
+
-
|
(R)-1-(2,6-Dichlorophenyl)ethanamine hydrochloride
This compound is primarily used in the pharmaceutical industry as a chiral intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its stereospecific structure makes it valuable in the production of enantiomerically pure drugs, particularly those targeting the central nervous system. It is often employed in the development of analgesics and anesthetics, where its specific configuration enhances the efficacy and reduces side effects of the final drug product. Additionally, it serves as a building block in organic synthesis for creating complex molecules with high pharmacological activity. Its application is critical in ensuring the desired therapeutic outcomes of medications while maintaining safety and regulatory compliance.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :